Taisuke Takahashi

USPTO Granted Patents = 10 (Patent Applications = 4)

EPO Patents = 4

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

The Salk Institute for Biological Studies

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

10 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12378200 - Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors (2025-08-05),

2. 11993585 - Poly-ADP ribose polymerase (PARP) inhibitors (2024-05-28),

3. 11780812 - Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors (2023-10-10),

4. 11578052 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2023-02-14),

5. 11034670 - Poly-ADP ribose polymerase (PARP) inhibitors (2021-06-15),

6. 10906885 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2021-02-02),

7. 10874641 - Methods of treating acute kidney injury (2020-12-29),

8. 10479775 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2019-11-19),

9. 10399958 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2019-09-03),

10. 10188627 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2019-01-29),

As I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can certainly help you with that. Let's get started with the article about inventor Taisuke Takahashi from Tsukuba, JP, who holds nine patents.

Title: The Innovations of Taisuke Takahashi

Introduction: Taisuke Takahashi is a renowned inventor hailing from Tsukuba, Japan, with a strong passion for pioneering pharmaceutical advancements through his patented discoveries.

Latest Patents: Takahashi's recent patents include groundbreaking innovations such as Poly-ADP ribose polymerase (PARP) inhibitors, aimed at treating diseases ameliorated by PARP inhibition, and Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors, targeting diseases benefiting from ACMSD inhibition.

Career Highlights: Takahashi has contributed significantly to the field of pharmaceuticals through his work at esteemed organizations like Mitobridge, Inc., and The Salk Institute for Biological Studies, where his expertise and inventive spirit have flourished.

Collaborations: Throughout his career, Takahashi has collaborated with talented individuals such as Bharat Lagu and Arthur F Kluge, enhancing his innovative capabilities and expanding the scope of his groundbreaking research.

Conclusion: In conclusion, Taisuke Takahashi stands as a beacon of innovation in the pharmaceutical industry, continually pushing boundaries and paving the way for transformative healthcare solutions with his visionary patents and collaborations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

4 patents pending:

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.